viewCallitas Health Inc

Callitas Health raises C$157,000 through debenture issue

Callitas Health is a clinical-stage company developing innovative technologies for obesity, weight management, and female health and wellness.

Canadian dollars
The company also announced that it has issued a total of 400,000 shares as partial consideration to two consultants.

Callitas Health Inc (CNSX:LILY) has completed its first closing of a non-brokered private placement of convertible debenture units.

Thus far, C$157,000 of convertible debenture units have been issued.

The debentures bear interest of 10% per annum for a term of two years and are convertible into common shares of the company at a conversion price of 50 cents per share.

Each unit consists of C$500 in shares at 25 cents (2,000 shares), C$500 in unsecured debentures and 2,000 warrants exercisable at 32 cents for a period of two years.

Proceeds from the issue will be used for general administrative expenses and to further certain of the company's development projects.

Quick facts: Callitas Health Inc

Price: - CAD

Market: CSE
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc named herein, including the promotion by the Company of Callitas Health Inc in any Content on the Site, the Company...



Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 25/4/19

2 min read